Filter Results:
(68)
Show Results For
- All HBS Web (499)
- Faculty Publications (186)
Show Results For
- All HBS Web (499)
- Faculty Publications (186)
Sort by
- 01 Dec 2013
- News
Your Own Medicine
pharmaceutical company, developing their own drugs. His offer was simple. "Is your son on any treatment that is a direct result of what you have done?" he asked. "No," admitted Tracy. "I'm going to change that," Williams said. DART... View Details
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
the business world has an important leadership role to play in terms of closing the gap in health and other vital social issues," he says. When Ray Gilmartin joined Merck in June 1994 as president and CEO (he became chairman several months later), it was the first time... View Details
- 08 Jun 2021
- News
New Funding for Female Founders
a patient’s home. “A pharmaceutical company, for instance, may want to study how well patients on a particular medication are able to sleep. HumanFirst can scan the clinical-research landscape to identify studies in which View Details
- 01 Jan 2008
- News
Jeffrey R. Immelt, MBA 1982
noting that GE has research centers in Munich, Shanghai, and Bangalore, in addition to its U.S. location in Niskayuna, New York. “That’s only going to accelerate over time.” The breakthroughs occurring in those View Details
- 01 Apr 1999
- News
Q & A: Confronting New Technologies: When Doing Right Is Wrong
Recently featured on the cover of Forbes with Intel chairman Andrew Grove, Associate Professor Clayton M. Christensen is the author of The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail. His research on "disruptive... View Details
- 01 Oct 1998
- News
Playing to Win
in turning losing teams into winners, Louis-Dreyfus has an enviable record of reshaping underperforming companies into formidable competitors. A scion of one of France's most prominent business families, he rejuvenated IMS International, a struggling U.S. View Details
Keywords: Garry Emmons
- 01 Sep 2011
- News
MBA 101: HBS Commencements Pass the Century Mark
pharmaceutical executive at the time of her diagnosis with multiple myeloma, an incurable, rare, and little-researched blood cancer, Giusti went on to found the Multiple Myeloma Research Foundation and the... View Details
- 01 Jun 2000
- News
The Business of Biotech
business and commercial development at Millennium Pharmaceuticals in Cambridge, Massachusetts. "It will revolutionize how medicine is practiced," he states simply. "Right now the doctor listens to your heart with a stethoscope and maybe... View Details
Keywords: Julia Hanna
- 01 Sep 2006
- News
HBS Student Battles ALS
returned home. While there, he served as the head of Israel’s ALS nonprofit organization, IsrALS, instituting a campaign that galvanized funding, awareness, and research efforts in that nation. Kremer returned to HBS last January. Since... View Details
- 01 Jan 2004
- News
Donald P. Nielsen, MBA 1963
the CEO of the world's largest independent biomedical research and testing company. He set off on a two-year "odyssey" around the United States to try to figure out what was wrong with this country's public education system. Then he ran... View Details
- 01 Jun 2000
- News
The Right Connections
From genome research to e-commerce, new ventures are popping up everywhere, competing for the cash needed to turn them into successful enterprises. When trying to secure backing for a high-risk start-up, whom you know can be just as... View Details
Keywords: Judith A. Ross
- 01 Dec 2010
- News
This Is What I Do
2002) to research and fight Parkinson’s, which afflicts some 5 million people worldwide, including 1 million Americans. Not only is the MJFF acknowledged to be the driving force behind Parkinson’s-related R&D, it is a benchmark... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
If you are one of the 17 million people who participated in the Ice Bucket Challenge a couple of summers ago, the money you helped raise to support ALS research may be at work today in a late-stage biopharmaceutical company headed by... View Details
Keywords: Deborah Blagg
- 15 Dec 2015
- News
The Year in Ideas 2015
From social media to the grocery store to the corner office and all the way to the stratosphere, the research and entrepreneurial adventures HBS faculty, doctoral students and alumni undertook this year have changed the way we understand... View Details
- 01 Sep 2012
- News
What’s the Big Idea?
experiencing,” says Amabile, who gathered and analyzed the data with the help of HBS research associates and doctoral students, ultimately writing The Progress Principle: Using Small Wins to Ignite Joy, Engagement, and Creativity at Work... View Details
- 23 Oct 2019
- News
After the Storm
class. When I started at Johnson & Johnson right after business school, I remember being the only African American female pharmaceutical sales rep in the mid-Atlantic region at that time. It’s a sad reality, but that is also why I get so... View Details
- 01 Jan 2003
- News
Greylock
retired U.S. Army brigadier general) Georges F. Doriot, who had founded American Research & Development Corp. (AR&D) in 1946, the first public venture capital firm in the United States. As the American economy began to soar after World... View Details
- 01 Dec 2001
- News
Reaching Out
Ph.D. in pathology and molecular biology at Boston University's School of Medicine. Intrigued by his experience with pharmaceutical companies and the role of business in drug delivery, he enrolled at HBS one month after finishing his... View Details
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
& Co., kicked off the first plenary session with a quick overview of factors contributing to the U.S. pharmaceutical industry's success in competing in the global market. Among other ad- vantages, Gilmartin cited the U.S. government's... View Details